TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | -6 | 19 | 90 | 82 | 62 | 41 |
| P | %wins | 0 | 0 | 100 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/26/18 16:49 | 6/25/18 | APTX | Aptinyx Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gantz Wilbur H | IL | D | P.d | 370 | 16.00 | 0 | 23 | 40 | 80 | I | |||||||||||||||
10/18/17 16:16 | 10/17/17 | GNMX | Aevi Genomic Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gantz Wilbur H | PA | D | P.d | 50 | 1.26 | 0 | 40 | 126 | 71 | D | |||||||||||||||
12/2/14 08:58 | 12/1/14 | MDGN | Medgenics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gantz Wilbur H | PA | D | P | 100 | 4.10 | 0 | 24 | 348 | 31 | D | -49 | -35 | -43 | -31 | -14 | -19 | -11 | 0 | -2 | -6 | 19 | 90 | 82 | 62 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |